Zobrazeno 1 - 10
of 144
pro vyhledávání: '"I.L. Davydkin"'
Publikováno v:
Bulletin of Medical Science. :37-42
FEATURES OF HEMOSTASIS IN ONCOHEMATOLOGICAL PATIENTS WHO HAVE UNDERGONE COVID-19 (LITERATURE REVIEW)
Publikováno v:
Bulletin of Medical Science. :70-74
Autor:
Geliya Rifkatovna Gimatdinova, O.E. Danilova, I.L. Davydkin, R.K. Khairetdinov, L.A. Rogozina
Publikováno v:
Clinical oncohematology. 15:107-113
This analysis presents literature data, derived from open authoritative medical sources, dealing with current methods for earliest diagnosis of cardiotoxic complications, especially in the period of their subclinical manifestations. Opportunities and
Autor:
Sabanova V.D. Sabanova, Gimatdinova G.R. Gimatdinova, Davydkin I.L. Davydkin, Zolotovskaya I.A. Zolotovskaya
Publikováno v:
Therapy. :32-41
Autor:
L.G. Basalaeva, V.M. Chernov, M.A. Timofeeva, E.V. Gapchenko, N.I. Zozulya, V. V. Shkryabunova, O.A. Krasheninnikova, I.N. Lavrentieva, T.V. Asekretova, A.Yu. Borozinets, O.A. Markova, Tatiana Andreeva, V.Yu. Petrov, K.G. Kopylov, Dmitry Kudlay, A.A. Rumyantsev, Saint Petersburg City Polyclinic No. , Saint Petersburg, Russia, E.E. Shiller, Igor Kurtov, Pavel Svirin, I.A. Lavrichenko, A.N. Mamaev, Vladimir Vdovin, Immunology named after Dmitry Rogachev, Moscow, Russia, Childhood Protection, Barnaul, Altai Krai, Russia, I.L. Davydkin, V.V. Lebedev
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:236-245
Currently, the main method of treatment for hemophilia A is replacement therapy with drugs of blood coagulation factors VIII (FVIII). As a result of the development of new production technologies, recombinant FVIII are increasingly used for the treat
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vladimir Vdovin, Tatiana Andreeva, V.V. Lebedev, I.L. Davydkin, A.Yu. Borozinets, Saint Petersburg City Polyclinic No. , Saint Petersburg, Russia, I.S. Tarasova, Pavel Svirin, E.E. Shiller, Dmitry Kudlay, Immunology named after Dmitry Rogachev, Moscow, Russia, Igor Kurtov, I.A. Lavrichenko, E.V. Gapchenko, V.Yu. Petrov, O.A. Markova, M.A. Timofeeva, T.V. Asekretova, O.A. Krasheninnikova
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 99:190-198
Providing hemophilia patients with blood coagulation preparations is one of the priority tasks of the national health care system. In 2011, the first recombinant factor IX was created in Russia (rFIX, nonacog alpha, Innonafactor, GENERIUM JSC), that
Assessing risks of developing myeloproliferative diseases complications with laser doppler flowmetry
Publikováno v:
Health Risk Analysis. :160-168
Public healthcare in Russia faces many challenges; meeting them requires non-standard and innovative approaches. The set tasks are being solved within the «Public healthcare development» State program. A sub-program within it is called «Developmen
Autor:
Danilova O.E. Danilova, Shatunova E.P. Shatunova, Davydkin I.L. Davydkin, Lineva O.I. Lineva, Kurtov I.V. Kurtov, Tarasova A.V. Tarasova
Publikováno v:
Akusherstvo i ginekologiia. :170-176
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 99:88-93